Skip to main content
Clinical Trials/NCT01020032
NCT01020032
Completed
Not Applicable

Effect of Music Therapy on Chronic Pain in Hospitalized Patients in a Pain Center

Association de Musicothérapie Applications et Recherches Cliniques1 site in 1 country87 target enrollmentSeptember 2006
ConditionsChronic Pain

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Pain
Sponsor
Association de Musicothérapie Applications et Recherches Cliniques
Enrollment
87
Locations
1
Primary Endpoint
Score on a Visual Analogical Scale (VAS) for actual pain
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The aim of study is to assess the effects of this new music therapy technique on pain treatment, anxiety and depression and on medicinal consumption.

Detailed Description

The "U" technique is a music therapy method of recent use developed by taking into account recommendations of the scientific literature. The objective of the study is to evaluate this method on chronic painful patients presenting a lumbago, a fibromyalgia, an inflammatory or neurological pathology. During the hospitalization, the intervention group benefited from at least 2 daily sessions of music therapy between day 0 and day 10, and continued the musicotherapy at home until day 60. The evaluated criteria are pain, depression and anxiety and their evolution after 60 days of treatment (since the inclusion). The evaluation at day 90 allows to test the persistence of the effect of the music therapy 90 days later.

Registry
clinicaltrials.gov
Start Date
September 2006
End Date
December 2008
Last Updated
16 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Association de Musicothérapie Applications et Recherches Cliniques

Eligibility Criteria

Inclusion Criteria

  • Have a pain for more than 6 months
  • Pain of neurological origin (fibromyalgia, algodystrophies), or skeletal musculous (back, sciatic nerve)
  • Speak and read French fluently
  • Wrote consent of patients
  • Benefit from the standard treatment : Intravenous treatment (tranquillizer, antidepressive) the first 5 days, 2 time by day (in the morning and evening), followed by the intermediary orally up to the exit (prescribed doses and at request)

Exclusion Criteria

  • Time of hospitalization \< 8 days
  • Reflex epilepsy history
  • Major insufficiency of auditory function
  • Patient with a strong possibility of not compliance to the protocol or of abandon in the course of study
  • Presence of an illness threatening vital forecast during period envisaged for the study

Outcomes

Primary Outcomes

Score on a Visual Analogical Scale (VAS) for actual pain

Time Frame: Day 0, day 5, day 10, day 60 and day 90

Secondary Outcomes

  • Score on the Hospital Anxiety and Depression (HAD) Scale(Day 0, day 5, day 10, day 60 and day 90)
  • Medicinal consumption(Before hospitalization, day 0, day 5, day 10, day 60 and day 90)

Study Sites (1)

Loading locations...

Similar Trials